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Abstract
Introduction
Although production of polybrominated diphenyl ethers (PBDEs) is now banned, release
from existing products will continue for many years. The PBDEs are assumed to be neuro-
toxic and toxic to endocrine organs at low concentrations. Their effect on the immune sys-
tem has not been investigated thoroughly. We aimed to investigate the influence of DE-71
on cytokine production by peripheral blood mononuclear cells (PBMCs) stimulated with
Escherichia Coli lipopolysaccharide (LPS) or phytohaemagglutinin-L (PHA-L).
Material and Methods
PBMCs isolated from healthy donors were pre-incubated with DE-71 at various concentra-
tions and subsequently incubated with the monocyte stimulator LPS, or the T-cell activator
PHA-L. Interferon (IFN)-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, tumor necrosis fac-
tor (TNF)-α, IL-17A, and IL-17F were quantified in the supernatants by Luminex kits.
Results
At non-cytotoxic concentrations (0.01–10 μg/mL), DE-71 significantly enhanced secretion
of IL-1β, IL-6, CXCL8, IL-10, and TNF-α (p<0.001–0.019; n = 6) from LPS-stimulated
PBMCs. IFN-γ, TNF-α, IL-17A, and IL-17F (p = <0.001–0.043; n = 6) secretion were
enhanced from PHA-L-stimulated PBMCs as well. Secretion of IL-1β, IL-2, IL-10, IL-8 and
IL-6 was not significantly affected by DE-71.
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Conclusions
We demonstrate an enhancing effect of DE-71 on cytokine production by normal human
PBMCs stimulated with LPS or PHA-L ex vivo.
Introduction
Polybrominated diphenyl ethers (PBDEs) are used in flame retardant mixtures to reduce flam-
mability in electronic equipment, upholstery, textiles, plastics, and building materials [1]. Com-
mercial production of the lower brominated PentaBDE and OctaBDE mixtures was banned in
the European Union (EU) in 2004, and phased out in the USA in 2005 [1–4] due to increasing
concerns about adverse physiological effects and biological persistence of the compounds [5–
7]. The Penta- and OctaBDE mixtures have been on the Stockholm convention list since 2009,
giving them status as global persistent organic pollutants. However, because of a long life-time
of some products, PBDEs will continue to leak from existing products for many years [1].
Ongoing human exposure in combination with year-long PBDE elimination half-lives [8] will
result in substantial PBDE accumulation in humans in the future. One of the commercial mix-
tures of PBDEs was the PentaBDE mixture DE-71. DE-71 consists of a specific combination of
congeners similar to the combination found in dust and indoor air, two potential exposure
pathways. This combination of congeners can still be recognised in human samples, such as
blood, placenta, amniotic fluid, and breast milk [9, 10]. The PBDEs are assumed to be neuro-
toxic, and toxic to reproductive and other endocrine organs at low concentrations [1, 11, 12].
Besides, they have been suggested to have immune modulating effects [13–16].
One of many measurable immunologic end points is cytokine secretion [15, 17–20]. Tumor
necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 characterise pro-inflammatory,
innate immune reponses, while interferon-γ (IFN-γ), IL-2, IL-13 and IL-17 characterise T-cell
responses, and thereby adaptive immune responses.
The aim of the present study was to investigate the influence of DE-71 on cultures of human
peripheral blood mononuclear cells (PBMCs) stimulated with Escherichia (E.) coli lipopolysac-
charide (LPS), an activator of monocytes/macrophages, or the T-cell activator phytohaemag-
glutinin-L (PHA-L). Unlike most other studies on cellular toxicity, we measured PBDE levels
in selected samples of the stock solutions, culture media as well as in supernatant samples and
cell remnants after DE-71 exposure.
Material and Methods
Subjects
Blood samples were drawn from a total of six healthy, anonymous, female and male volunteers
at Rigshospitalet. Fresh blood was collected in sodium-heparin tubes (Vacutainer, Becton
Dickinson, Franklin Lakes, NJ) 20 to 30 minutes prior to initiation of the experiment.
Cell Cultures
PBMCs were isolated by density centrifugation (Ficoll-Hypaque, Almeco, Esbjerg, Denmark
and Lymphoprep, Axis-Shield, Oslo, Norway), washed thrice in phosphate buffered saline
(PBS without calcium and magnesium from Gibco, Invitrogen, Thermo Fischer Scientific, Wal-
tham, MA), and re-suspended in Hams F12 growth media (Panum Institute, Copenhagen,
Denmark), supplemented with 5% foetal bovine serum (Biological Industries, Beit HaEmek,
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Israel), 0.029% L-glutamin (Panum Institute, Copenhagen University, Denmark), non-essen-
tial amino acids and Penicillin/Streptomycin (Gibco, Invitrogen, Thermo Fischer Scientific,
Waltham, MA). All experiments consisted of three 24 well plates with final concentrations of
106 cells per well (NUNC, Roskilde, Denmark).
DE-71 and Stimulation
DE-71, a gift kindly provided by Marta Axelstad, National Food Institute, Technical University
of Denmark and Dr. Kevin Crofton of the U.S. Environmental Protection Agency, was dis-
solved in dimethyl sulfoxid (DMSO) (D2438 Sigma Aldrich, St. Louis, MO) and diluted in cell
culture medium to final concentrations of 0.01, 0.1, 1, 5, and 10 μg/mL, respectively. Three
standards in DMSO and two standards in cell culture medium were analysed to determine
PBDE concentrations, as described below. The DMSO concentration in each well was 1‰. Cell
cultures with DE-71 were pre-incubated for one hour at 37°C and 5% CO2. Subsequently, LPS
from E. coli (100 pg/mL) or PHA-L (5 μl/mL, both with CAS 9008-97-3, from Sigma-Aldrich,
St. Louis, MO) was added. Unstimulated PBMCs, i.e. cell cultures exposed to DE-71 but with-
out LPS or PHA-L stimulation, were also investigated. Cultures were further incubated for 20
to 22 hours, centrifuged for 10 min. at 460 x G at 4°C, and supernatants were harvested and
stored at -20°C. All measurements of DE-71 were performed in duplicate, except for two sam-
ples where only single determinations were done (one sample of 0.1 μg/mL DE-71; one DMSO
control). All experiments included a culture medium-control and a culture medium-control
with 1‰DMSO added. The 1‰DMSO control was used for statistical analysis.
Cytokine Assessment
The content of IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, IL-17A, and IL-17F in PBMC
culture supernatants after 18 hours of incubation was measured by luminex kits (Biorad Labo-
ratories Inc., Hercules, CA) according to the manufacturer’s protocol. A LUMINEX 100 system
(Luminex Cooperation, Austin, TX) was used for the analysis. The intra- and inter-assay varia-
tions (% CV) were 2–3% and 3–8% for the chemokine kit, and 4.3% and 5.8% for the Th17
cytokine kit, respectively, as stated by the manufacturer. The calibration ranges in the assays
were specific for each cytokine (total range: 0.4–38,787 pg/mL).
Cytotoxicity Assessment
DE-71 induced cytotoxicity was analysed by assessing the content of lactate dehydrogenase
(LDH) in cell culture supernatants as described [21]. For this purpose, a homogenous mem-
brane integrity assay, CytoTox-ONE™ (Promega, Fitchburg, WI), was applied according to the
manufacturer’s protocol with the modification that LDH was not measured directly in cell cul-
tures but in harvested supernatants. The CytoTox-ONE™ passes the following quality control,
according to the manufacturer: average background< 20% of the average relative flouroscense
unit generated by LDH equivalent to 50,000 cells, LDH activity equivalent to 1,562 cells, fluo-
rescence produced by LDH activities ranging from 0 to 50,000 cells with an R2 0.95. Briefly,
frozen harvested cell culture supernatants were thawed, mixed by vortex, stimulated with LPS
or PHA-L, and exposed to 0.01, 0.1, 1, 5, 10, and 50 μg/mL DE-71 (n = two blood cell cultures
set up in triplicates). Harvested cell culture supernatants from the culture medium control with
or without DMSO served as negative control. Fifty μl of each culture medium were transferred
to a 96-well microwell plate (Th. Geyer, Renningen, Germany), followed by addition of 50 μl
CytoTox-One reagent (Promega, Fitchburg, WI) to all wells. The microwell plate was mixed
gently on a shaker and incubated at room temperature for 10 to 15 minutes. Hereafter, 25 μl
stop solution was added, the plate was shortly shaken, and results were read on a fluorometer
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(Victor2, PerkinElmer, Waltham, MA). The LDH contents were proportional to the generated
fluorescence (given in relative flourescense units), which was used to evaluate the toxicity of
DE-71. The DMSO-concentration was 1‰ in the negative culture medium control and in cell
cultures, to which 50, 10 or 5 μg/mL DE-71 had been added. In samples/cell cultures where 1,
0.1 or 0.01 μg/mL DE-71 had been added, the DMSO concentrations were 0.2‰, 0.02‰ and
0.002‰, respectively.
Endotoxin Test
All reagents were tested for endotoxins by the Limulus Amebocyte Lysate QCL-1000 assay
(Lonza, Basel, Schwitzerland).
PBDE Analysis
Two supernatants and two cell samples (addition of DE-71 at concentrations of 10 μg/mL and
0.01 μg/mL respectively), two controls (1‰DMSO), three stock solutions of DE-71 in DMSO,
and two solutions of DE-71 in culture media were analysed for content and composition of
BDE-congeners. This was done after the cytokine analysis using once-thawed samples. The
analysis followed accredited methods for PBDEs in biota, as described elsewhere [22], and
included 11 tri- to heptabrominated congeners (BDE-17, 28, 47, 49, 66, 85, 99, 100, 153, 154
and 183). Between batch analyses of the in house reference material (n = 18), sand eel oil, var-
ied from 2.7% (BDE-47) to 14% (BDE-17), with a mean of 6.6% for all congeners. The detec-
tion limits of the instrument ranged between 0.05 and 0.25 pg. Briefly, the samples were spiked
with recovery standards, dried with diatomaceous earth (Varian) and Soxhlet extracted with
hexane:acetone (4:1). The extracts were cleaned up on a multilayer column consisting of alu-
minium oxide, silica, and acidified silica. After elution, volume reduction and addition of the
internal standard (BDE-71, Cambridge Isotope Laboratories, Tewksbury, MA), the samples
were analysed by gas chromatography—mass spectrometry (GC-MS) with electron capture
negative ionization. Quantification was based on two calibrations of ten standards each (0.05–
25 ng/mL). Three spiked control samples were extracted together with the samples. The DE-71
standards in DMSO, along with four spiked control samples, were evaporated to dryness in sili-
cone vials [22], re-dissolved in iso-octane including the internal standard and analysed without
further clean-up.
Ethics
The study was approved by The Danish committees on health research ethics, Capital region
(Protocol number: H-1-2012-110 and additional protocol 44717), which in Denmark/Copen-
hagen also functions as the institutional review board. According to the committee law by the
Danish Committees on Health Research Ethics, neither written nor oral informed consent is
needed in studies of anonymous human blood samples, which was the case in this study. Blood
samples of this study were drawn from anonymous healthy human volunteers, whose identity
were unknown to the investigators, and thus the institutional review board waived the need for
written informed consent from the participants.
Statistical Analysis
The cytokine concentrations (mean of duplicates) were analysed by two-way ANOVA followed
by Tukey’s honest significant difference post hoc analysis. Data was Ln-transformed when nec-
essary. Relevant results of Tukey’s post hoc analysis are shown in Figs 1 and 2, described in
Results and listed in Table A and B in S1 File with p-values and 95% confidence intervals (CI).
DE-71 and Immune Cell Cytokine Responses
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The negative controls were compared by paired t-tests. No statistical analysis was performed
for cytotoxicity assessment, since only two cell experiments were done. However, cytotoxicity
data are presented in graphs as means ± SD. Results were considered statistically significant
when p< 0.05.
Results
Cytokine Secretion from Unstimulated Cells
In culture medium from unstimulated PBMCs, the levels of all cytokines (IL-1β, IL-2, IL-4, IL-
6, CXCL8, IL-10, IL-17A, IL-17F, TNF-α, and INF-γ) were far below levels of LPS- or PHA-L-
stimulated cells, and were not further investigated (data not shown).
Cytokine Secretion from LPS-Stimulated PBMCs
Median and ranges for the DMSO controls with LPS stimulation are shown in Table 1. DE-71
significantly increased the secretion of IL-1β, IL-6, CXCL8, IL-10, and TNF-α (p = 0.005,
p = 0.019, p = 0.012, p = 0.009, and p<0.001, respectively; n = 6) from the LPS-stimulated
PBMCs, as shown in Fig 1. DMSO had no effect on cytokine secretion compared to medium
alone (IL-1β: p = 0.72, IL-6: p = 0.33, IL-8: p = 0.08, IL-10: p = 0.45, TNF-α: p = 0.53) (n = 6
cultures in duplicate, data not shown).
Concentrations of INF-γ, IL-2, IL-4, IL-17A, and IL-17F were generally below the lowest
standard, and therefore no further analyses of these data were performed (data not shown).
Post-hoc analysis showed a significant increase of IL-1β, IL-6, CXCL8, IL-10, and TNF-α
secretion in cultures exposed to 5 and 10 μg/mL DE-71, compared to controls. A few other DE-
71 concentrations also caused significant increases in TNF-α secretion (Fig 1, exact values are
Fig 1. Influence of DE-71 on cytokine responses of PBMCs.Mean + SD of secretion of IL-1β, IL-10, TNF-
α, IL-8, and IL-6 from DE-71 exposed and LPS-stimulated PBMCs are shown as ratios to the respective
DMSO controls. The red dotted line indicates the level of the DMSO controls (ratio = 1). * = p<0.05 compared
to DMSO control, # = p<0.05 compared to 0.1 μg/mL DE-71. PBMC: peripheral mononuclear cells, LPS:
lipopolysaccharide, IL-1β: interleukin-1β, IL-10: interleukin-10, TNF-α: tumor necrosis factor-α, IL-8:
interleukin-8, IL-6: interleukin-6, DMSO = dimethyl sulfoxide, SD = standard deviation.
doi:10.1371/journal.pone.0154621.g001
DE-71 and Immune Cell Cytokine Responses
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listed in Table 1 in S1 File). Three out of six cultures showed a tendency towards an increase in
IL-1β, IL-10, and TNF-α upon addition of 0.01 μg/mL DE-71, compared to relevant controls
visualised in Fig 1. Increasing the concentration further to 0.1 μg/mL caused a slight, albeit
non-significant decrease in cytokine production (data not shown).
Cytokine Secretion from PHA-L-Stimulated PBMC
Median and ranges for the DMSO controls with LPS stimulation are shown in Table 2. The dif-
ferences found in the post hoc analysis are listed in Table B in S1 File. DE-71 significantly
enhanced the PHA-L-elicited secretion of IFN-γ, TNF-α, IL-17A, and IL-17F (with p-values of
0.016, 0.043,< 0.001 and< 0.001, respectively; n = 6) (Fig 2), while secretion of IL-1β, IL-2,
IL-10, IL-8 and IL-6 was not significantly affected by DE-71) (with p-values of 0.071, 0.19,
Fig 2. Influence of DE-71 on cytokine responses of PBMCs.Mean + SD of secretion of TNF-α, IFN-γ, IL-
17A, and IL-17F from DE-71 exposed and PHA-L-stimulated PBMCs are shown as ratios to the respective
DMSO controls. The red dotted line indicates the level of the DMSO controls (ratio = 1). * = p<0.05 compared
to DMSO control, # = p<0.05 compared to 0.01 μg/mL DE-71, + = p<0.05 compared to 0.1 μg/mL DE-71, ¤ =
p<0.05 compared to 1 μg/mL DE-71. PBMC: peripheral mononuclear cells, PHA-L: phytohemagglutinin-L,
TNF-α: tumor necrosis factor-α, IFN-γ: interferon-γ, IL-17A: interleukin-17a, IL-17F: interleukin-17F DMSO =
dimethyl sulfoxide, SD = standard deviation.
doi:10.1371/journal.pone.0154621.g002
Table 1. Median and range of DMSO controls from LPS-stimulated PBMCs (n = 6 cultures in
duplicates).
Stimulation Cytokine Median (pg/mL) Range (pg/mL)
LPS IL-1β 198 80–1064
IL-10 48 7.4–183
TNF-α 887 451–2065
CXCL8 42930 13037–84622
IL-6 6284 1944–15582
doi:10.1371/journal.pone.0154621.t001
DE-71 and Immune Cell Cytokine Responses
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0.070, 0.14; n = 6 cultures in duplicates; data not shown and 0.40; n = 5 due to unmeasurable
values in one experiment, respectively).
DMSO did not seem to affect the cytokine secretion compared to medium alone (range of
p-values, 0.06–0.66), except for that of IL-17A (p = 0.024) (n = 6 cultures in duplicates, data
not shown). The concentration of IL-4 was generally below the detection limit in all experi-
ments and therefore not subjected to further analysis (data not shown).
Although the post-hoc analyses did not show any significant differences (data not shown),
and a true dose-response relationship could not be defined, lower concentrations of DE-71
seemed to stimulate IFN-γ secretion, while higher concentrations were associated with IFN- γ
levels similar to those of the control (Fig 2). There was a tendency towards a dose-response
increase of DE-71 on TNF-α release (Fig 2). However, this was only significant for 10 μg/mL
DE-71, compared to the control in the post-hoc analysis (Fig 2, Table B in S1 File). The secre-
tion of both IL-17A and IL-17F was inhibited by 5 and 10 μg/mL DE-71, compared to the
lower DE-71 concentrations, and for IL-17A also to the control (Fig 2).). Conversely, the secre-
tion of both IL-17A and IL-17F tended to increase upon exposure of PMBCs to the lower con-
centrations of DE-71, but thiswas not confirmed in the post-hoc analysis.
Cytotoxicity
DE-71, at a concentration of 50 μg/mL, caused an increase in LDH-levels compared to the neg-
ative control, while no increase was observed at lower DE-71 concentrations. DMSO had no
effect on cytotoxicity compared to culture medium controls (Fig 3 + Fig 4).
Endotoxin Test
All results were negative.
Table 2. Median and range of DMSO controls from PHA-L-stimulated PBMCs (n = 6 cultures in
duplicates).
Stimulation Cytokine Median (pg/mL) Range (pg/mL)
PHA-L TNF-α 638 110–1414
IFN-γ 19 8.6–534
IL-17a 76 4.8–113
IL-17f 493 11–1161
doi:10.1371/journal.pone.0154621.t002
Fig 3. Mean of LDH-fluorescence from DE-71 exposed and LPS-stimulated PBMCs.DE-71 was added
in six different concentrations to each culture and medium, and DMSO in medium served as negative controls
in duplicate, n = 2 cultures in triplicates. LDH: lactate dehydrogenase, LPS: lipopolysaccharide, DMSO:
dimethyl sulfoxid, RFU: relative fluorescence unit.
doi:10.1371/journal.pone.0154621.g003
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PBDE analysis. The PBDE analysis showed a consistent congener pattern in all samples,
the dominating congener being BDE-99 (50.1%), followed by BDE-47 (28,5%) and BDE-100
(8,9%). The concentration of DE-71, calculated as the sum of the PBDE congeners, in three
stock solutions and in culture medium deviated slightly from the expected concentrations
(Table 3). The deviation increased throughout the serial dilution. The spiked control samples
analysed along with the DMSO solutions, ranged from 102% (BDE-100) to 107% (BDE-183)
(mean of four control samples).
Analysis of cell samples and supernatants showed that the majority of DE-71 was present in
the supernatant. At a concentration of 0.01 μg/mL, DE-71 could be recovered completely from
the chemical analysis, while the absence of a valid result for the supernatant of cultures stimu-
lated with 10 μg/mL DE-71 made the mass balance calculation for this sample more uncertain.
The spiked control samples extracted together with the samples ranged from 80% (BDE-183)
to 96% (BDE-47) (mean of three control samples). The analyses of controls containing only
DMSO showed trace levels of BDE-99 (< 0.2 ng/mL).
Fig 4. Mean of LDH-fluorescence from DE-71 exposed and PHA-L-stimulated PBMCs.DE-71 was
added in six different concentrations to each culture, medium and DMSO in medium served as negative
controls in duplicate, n = 2 cultures in triplicates. LDH: lactate dehydrogenase, PHA-L: phytohemagglutinin-L,
DMSO: dimethyl sulfoxid, RFU: relative fluorescence unit.
doi:10.1371/journal.pone.0154621.g004
Table 3. PBDEmeasurements in stock solution, culture media and cells, mean of double
determinations.
Sample type Measured concentration
Stockk sollutions (mg/mL) 4.2
7.4
0.03
Culture media (μg/mL) 2.6
0.2
Cells after exposure (μg/mL) Supernatant Cell remnants
1.7 a) 1.6
0.008 0.003
a) The concentration was outside the calibration range and thus likely underestimated.
doi:10.1371/journal.pone.0154621.t003
DE-71 and Immune Cell Cytokine Responses
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Discussion
The effect of PBDEs on the immune system is largely unknown. In this study, we have demon-
strated an enhancing, non-cytotoxic effect of DE-71 (0.01–10 μg/mL) on cytokine production
by normal human PBMCs stimulated with LPS or PHA-L ex vivo.
The cytokine pattern found for LPS-stimulated cells indicated that DE-71 enhanced pro-
inflammatory responses by monocytes and macrophages, reflected by increasing secretion of
TNF-α, IL-1β, IL-6, and IL-8. Secretion of the anti-inflammatory IL-10 was increased as well,
possibly reflecting a subsequent compensatory down-regulation of an anti-inflammatory
response [23, 24]. Thus, DE-71 appeared to enhance pro-inflammatory responses by innate
immune cells.
To examine the effect of DE-71 specifically on the adaptive immune system, PBMCs were
stimulated with PHA-L. DE-71 tended to enhance PHA-L-induced IFN-γ responses at low
concentrations (0.01–1 μg/mL) (Fig 2), supporting a promotion of Th1-cell responses. This
conclusion was supported by an enhancing effect of DE-71 on TNF-α production, while not
supported by statistical analyses of IFN-γ responses alone. High concentrations of DE-71
caused a reduction of the PHA-L-induced IL-17A and IL-17F production, indicating suppres-
sion of Th17-cell responses, in a greement with Th17 responses usually being suppressed by
Th1 cytokines [25]. The apparent skewing of T-cell responses towards a Th1-response, and
away from Th17 responses might indicate that defence against infection with extracellular bac-
teria and fungi, which normally requires Th17 responses [26, 27], may be compromised by
DE-71. It can further be speculated that inappropriate activation of the Th1 cells might facili-
tate development of autoimmune disease [28].
It is difficult to compare these findings with other studies, since studies concerning PBDE
effects on immune cells in vitro and ex vivo are few, with a wide range of different endpoints
and mixed conclusions. Only few studies have investigated cytokine responses: Koike et al. [29]
found increased production of IL-4 (pg/mL) and increased antigen expression in mouse
immune cells (splenocytes and bone marrow cells) after addition of five different flame retar-
dant mixtures to final concentrations of 0.1–10 μg/mL. Koike et al. used concentrations of DE-
71 that were comparable to ours, but stimulated the cells with granulocyte macrophage-stimu-
lating factor rather than PHA-L or LPS, which may explain why their findings differed from
ours. Hennigar et al. [13] found reduced TNF-α and IL-6 (pg/mL) secretion in porcine alveolar
macrophages after addition of seven different concentrations of DE-71 (ranging from
0.0001 μg/mL to 2 μg/mL. These findings are in disagreement with our finding of a lack of
effect on IL-4 (pg/mL), and enhancement of TNF-α and IL-6 responses. We used higher con-
centrations of DE-71 than Hennigar et al. (who used 0.1–2000 pg/mL), which may be one
explanation for the diverging results.
One study examined the effect of BDE-99, the mixture Bromkal 70-5DE which is very simi-
lar to DE-71, on several cytokines (IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12,
IL-13, IL-17, IFN-γ, CXCL1, MCP-1, MIP-1β, RANTES, TNFα, and VEGF) ex vivo, and on
replication of microorganisms in coxsackievirus-infected mice [30]. PBDEs caused a drastic
reduction in circulating cytokine concentrations in non-infected mice, to a higher degree than
in infected mice. The discrepancy of these findings from ours may relate to differences in cell
type, cell stimuli, methods of cytokine measurements, or exposure time.
Many protocols have been used to study the effects of PBDEs on human cells in vitro. One
study investigated immunoglobulin synthesis and proliferation of lymphocytes incubated for
72 hours with two congeners, BDE-47 (4.8510−4–4.85 μg/mL) and BDE-85 (5.6510−4–5.65
μg/mL), i.e. at concentration ranges lower than those used in our study, and found no signifi-
cant effect of these compounds [19]. Koike et al. used 24 hours incubation with DE-71 and two
DE-71 and Immune Cell Cytokine Responses
PLOS ONE | DOI:10.1371/journal.pone.0154621 April 29, 2016 9 / 13
other commercial mixtures to examine the effect on ICAM-1, IL-6 and IL-8 expression in
human bronchial epithelial cells pre-treated with protein kinase inhibitors or nuclear receptor
antagonists [31]. As in the present study, they also diluted DE-71 in DMSO (1‰) and culture
medium to final concentrations of 0.01–10 μg/mL. Neither study found any cytotoxicity at con-
centrations ranging from 0.01–10 μg/mL. Koike et al. measured the cytokine content by
enzyme-linked immunosorbent assay, while in the current study a cytometric bead-array sys-
tem was used. They found an increased production of IL-6, and IL-8, in accordance with our
demonstration of an enhancement from DE-71 on the production of these mediators by LPS-
stimulated cells. Thus, a proinflammatory reaction similar to that of PBMCs occurred in bron-
chial epithelial cells. Finally, both data and the description above indicated a direct effect of
PBDEs on cytokine production.
The composition of the DE-71 mixture used in this study was in good agreeement with the
profile of DE-71 specifed by La Guardia et al. [32], and remained unchanged throughout dilu-
tions. Consistent with the chemical analysis, which only showed unquantifiable traces of
PBDEs in the control samples, no traces were observed in cell controls without addition of DE-
71. Our analysis further showed a partitioning of the PBDEs between cell supernatants and
remnants. For one of the samples, the detectable amounts were in agreement with the expected
concentrations. However, an uncertain quantification in the second data set prevented an accu-
rate mass balance calculation of this sample. Several factors are likely to influence the PBDE
recovery, in particular sorption processes. Our findings underline that the quantification of
actual contaminant concentrations in the assays is important in toxicological research.
The PBMCs in our experiment were incubated with DE-71 for 20–22 hours. In comparison,
we investigated accumulation of DE-71 in human thyroid cells (unpublished) with an incuba-
tion time of 72 hours, where ~100% of the added DE-71 was recovered fromthe cell remnants.
Hence, it is plausible that DE-71 accumulates over time in human cells. The effect of different
exposure times in other such experiments is unknown, and further experiments are needed to
investigate these conditions.
The chosen concentrations of DE-71 were based on previous in vitro studies [29, 33], which
exceeded PBDE levels found in the indoor environment in Denmark [10], as well as in the
blood of Danish donors [22, 34]. These studies showed correlations between PBDEs in dust
and blood, suggesting that dust was a primary exposure source in humans. However, it is not
possible to extrapolate in vitro experiments to in vivo consequences. This might be due to
reduced effective doses of biologically test chemicals in vitro, evaporation in vitro and/or non-
specific binding to extracellular matrices. Furthermore, a limited number of target sites in cells
reduced the numberof toxicity pathways in vitro compared to pathways on a multi-organ level
[35]. It is important to note that a comparison between environmental exposure sources and
influences on cytokines in blood in vitro is not directly possible. The results, however, have
contributed to the elucidation of the cellular effect mechanism of a commercial flame retardant
mixture in PBMCs. Lower concentration ranges are suggested in future investigations consid-
ering our results. Consequences of the demonstrated specific cytokine response should be con-
sidered and compared to cytokine levels in normo- and pathophysiological conditions.
Of major importance for the future, new flame retardant chemicals sharing structural and
physico-chemical characteristics with the PBDEs have been found in dust samples in American
and European homes, including samples from Denmark [36–38]. The same adverse effects as
those observed after exposure to PBDEs may be expected for these new compunds but are
largely unknown. Further studies should include investigations of any immunotoxic mode of
action, as well as comparisons between the PBDEs and new flame retardants.
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Conclusion
Previous studies on DE-71 have suggested that it can influence the immune system in various
ways. Our results support this assumption: we showed that LPS- and PHA-L-induced cytokine
secretions by innate immune cells and T cells, respectively, were influenced by DE-71, at non-
cytotoxic concentrations (0.01–10 μg/mL), in vitro. DE-71 appeared to have an enhancing
effect on innate immune responses, as the production of all of the cytokines induced by LPS
stimulation were increased. Moreover, our study indicates that DE-71 promotes Th1 responses
and inhibits Th17 responses. These data thus add to earlier findings on cytotoxicity and pro-
inflammatory responses in human and animal cells. However, cytokine measurements have
been scarce and have in previous studies only dealt with few different cytokines per study.
More studies on the cytokine secretion patterns after DE-71 exposure are therefore warranted.
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